TGFB1 and autoimmune disease: These approaches have generally increased the production of immunosuppressive molecules, including IDO1, PGE2, and TGF-β1, which inhibited the functions of T cells, dendritic cells, and M1 macrophages and showed therapeutic effects in animal models of diverse autoimmune diseases [16,28,29,30,31,32].